Projects per year
Fingerprint
Dive into the research topics where Department of Pharmaceutical Sciences is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Mei-Chuan Chen
- Department of Pharmaceutical Sciences - Associate Professor
- Graduate Institute of Pharmacognosy - Joint-Appointment Associate Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Associate Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Associate Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Associate Professor
- TMU Research Center of Drug Discivery - Member
- TMU Research Center of Thoracic Medicine - Member
Person: Researcher
-
Yu-Wen Cheng
- Department of Pharmaceutical Sciences - Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- TMU Research Center of Drug Discivery - Member
- TMU Research Center of Cell Therapy and Regeneration Medicine - Member
- TMU Research Center of Neuroscience - Member
Person: Researcher
-
Shih-Jiuan Chiu
- Department of Pharmaceutical Sciences - Associate Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Associate Professor
Person: Researcher
-
「112年度「藥品品質規範國際協和化」委託辦理計畫」之「分項計畫二：原料藥及賦形劑品質規範國際協和化」
1/16/23 → 12/31/23
Project: A - Government Institution › c - Ministry of Health and Welfare
-
開發複合式三維度大腸直腸癌生物晶片：抗癌藥物於體外腫瘤微環境之療效評估
1/1/23 → 12/31/23
Project: C - Project of Alliance › m - National Taiwan University of Science and Technology
-
Development of Novel Mannose-Functionalized Covid-19 Virus-Mimicking Nanoparticles (Vmns) to Elicit Durable Antibodies and Cellular Immunity
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
-
Application of Design of Experiments in the Development of Self-Microemulsifying Drug Delivery Systems
Hsieh, C. M., Yang, T. L., Putri, A. D. & Chen, C. T., Feb 2023, In: Pharmaceuticals. 16, 2, 283.Research output: Contribution to journal › Review article › peer-review
Open Access -
Chemopreventive effects of Xiang Sha Liu Jun Zi Tang on paclitaxel-induced leucopenia and neuropathy in animals
Shiah, H-S., Lee, C-J., Lee, F-Y., Tseng, S-H., Chen, S-H. & Wang, C-C., 2023, In: Frontiers in Pharmacology. 14Research output: Contribution to journal › Article › peer-review
-
Design, Structure–Activity Relationships, and Enzyme Kinetic Studies of Tricyclic and Tetracyclic Coumarin–based Sulfamates as Steroid Sulfatase Inhibitors
Chiu, P-F., Lin, I-C., Lu, Y-L., Chang, C-N., Chan, H-Y., Lin, T-S., Tsai, K-C., S. Y. Hsieh, Y., Chen, M-J., Lin, M-H. & Liang, P-H., 2023, (Accepted/In press) In: Bioorganic Chemistry.Research output: Contribution to journal › Article › peer-review
Datasets
-
Prolonged exposure to traffic-related particulate matter and gaseous pollutants implicate distinct molecular mechanisms of lung injury in rats
Jheng, Y. (Creator), Putri, D. U. (Creator), Chuang, H. (Creator), Lee, K. (Creator), Chou, H. (Creator), Wang, S. (Creator) & Han, C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5484461.v1, https://doi.org/10.6084%2Fm9.figshare.c.5484461.v1
Dataset
-
Additional file 2 of Titanium dioxide nanoparticles impair the inner blood-retinal barrier and retinal electrophysiology through rapid ADAM17 activation and claudin-5 degradation
Li, C. (Creator), Ho, J. (Contributor), Chan, Y. (Contributor), Chen, C. (Contributor), Cheng, Y. (Creator), Lin, F. (Contributor), Liao, P. (Contributor) & Tsai, C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.13550761.v1, https://doi.org/10.6084%2Fm9.figshare.13550761.v1
Dataset
-
Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chang, L. (Contributor), Liou, J. (Creator), Lai, M. (Contributor), Chang, C. (Contributor), Tu, H. (Contributor), Chao, M. (Contributor), Pan, S. (Contributor), Chen, Y. (Creator) & Teng, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202902.v1, https://doi.org/10.6084%2Fm9.figshare.8202902.v1
Dataset